GPS ruined our sense of direction. Search engines weaken our memory. AI, scientists warn, could do the same to everything from creativity to critical thinking. Years ago, I forced myself to start ...

There are a few currencies to get to grips with in Mecha Break, but once you understand what each does, they are pretty easy to understand. The three currencies in Mecha Break are Corite, Matrix ...

Journalist Jo Ling Kent joined CBS News in July 2023 as the senior business and technology correspondent for CBS News. Kent has more than 15 years of experience covering the intersection of technology ...

Suffering from hair envy? You can now use the same hair products that Manon, Yoonchae, Sophia, Megan, Lara, and Daniela use to get their glossy locks. Manon's go-to products from Matrix are a ...

The woman allegedly killed the two men by giving them drinks mixed with drugs after asking ChatGPT how prescription drugs and alcohol interact Charlotte Phillipp is a Writer-Reporter at PEOPLE. She ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Most AI training teaches you how to get outputs. Write a better prompt. Refine your query. Generate content faster. This approach treats AI as a productivity tool and measures success by speed. It ...

Donald Trump did not win the 2024 election because America suddenly became meaningfully more Republican. He won because voters, many of them independents and crossover Democrats, many of them young, ...

Per the terms of the agreement, Novavax will receive an upfront payment of $30 million from Pfizer and is eligible to earn up to $500 million in potential development and commercial milestone payments ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...

Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...